Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-033697

SVP and Chief Development Off. gave up 1,850 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pavliv Leo SVP and Chief Development Off. 2019-05-21 Shares withheld for taxes −1,850 $6.30 $11,655 159,611 D
Loading xslF345X03/doc4.xml…